U.S. Markets closed

Valeant Pharmaceuticals International -- Moody's affirms Bausch Health's B3 CFR, revises outlook to positive

Moody's Investors Service ("Moody's") affirmed certain ratings of Bausch Health Companies Inc. ("Bausch") and its subsidiaries, and revised the rating outlook to positive from stable. In addition, Moody's upgraded Bausch's Speculative Grade Liquidity Rating to SGL-1 from SGL-2.